Skip to content

Discontinued — last reported Q4 '24

CapEx at other companies

Bausch Health Companies logo
Bausch Health CompaniesBHC
$109M-5.2%
Cumberland Pharmaceuticals logo
Cumberland PharmaceuticalsCPIX
$0-100%
PTH
Pelthos Therapeutics Inc.PTHS
$194K
Arcutis Biotherapeutics, Inc. logo
Arcutis Biotherapeutics, Inc.ARQT
$0-100%
HRO
HarrowHROW
$194K+14.1%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$27K

Other financials

Income statement

See full
Revenue$16.0M+21.5%
Gross profit$9.7M+16.7%
Operating income-$1.5M+55.1%
Net income-$2.2M+45.2%
EPS (diluted)-$0.08+55.6%

Balance sheet

See full
Cash & equivalents$27.2M+29.2%
Total debt$25.5M+1.2%
Total equity$30.8M+43.1%
Total assets$91.5M+7.7%

Cash flow

See full
Operating cash flow$2.9M+203%
Free cash flow-$6.0M

Valuation

See full
Market cap$194.94M+20.9%
Enterprise value$193.19M+16.2%
P/S+0.2×

Profitability

See full
Gross margin65.4%-1.0pp
Operating margin-9.8%
Net margin-14.8%
FCF margin-43%

Returns & leverage

See full
Return on equity-36.6%
Debt / equity0.8×-0.3×
Current ratio1.7×+0.4×

Where this comes from

Reported directly by Journey Medical Corporation in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireProductiveAssets.

The official record: Journey Medical Corporation’s 10-K, filed March 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Journey Medical Corporation's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Journey Medical Corporation's capex?
Journey Medical Corporation (DERM) reported capex of $3.75M in Q4 2024.
What does capex mean?
Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.